Cargando…

Minimizing Glycemic Fluctuations in Patients with Type 2 Diabetes: Approaches and Importance

Glycemic fluctuations, characterized by short-term oscillations in plasma glucose, are important when managing type 2 diabetes (T2D) and may be considered a target of glucose-lowering therapies. Continuous glucose monitoring (CGM) has been used to evaluate the effects of different treatments on glyc...

Descripción completa

Detalles Bibliográficos
Autor principal:	Dandona, Paresh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2017
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647495/ https://www.ncbi.nlm.nih.gov/pubmed/28771387 http://dx.doi.org/10.1089/dia.2016.0372

Ejemplares similares

Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
por: Makdissi, Antoine, et al.
Publicado: (2013)

Sodium‐glucose co‐transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician
por: Dandona, Paresh, et al.
Publicado: (2017)

Serum vitamin B12 levels and glycemic fluctuation in patients with type 2 diabetes mellitus
por: Li, Wei, et al.
Publicado: (2022)

Optimizing glycemic control and minimizing the risk of hypoglycemia in patients with type 2 diabetes
por: Schwartz, Stanley S
Publicado: (2013)

Association of the Glycemic Fluctuation as well as Glycemic Control with the Pancreatic β-cell Function in Japanese Subjects with Type 2 Diabetes Mellitus
por: Takai, Maiko, et al.
Publicado: (2018)

Effective Initiation and Treatment With Basal Insulin in People With Type 2 Diabetes: Focus on Mitigating Hypoglycemia in Patients at Increased Risk: Executive Summary
por: Anderson, John, et al.
Publicado: (2020)

Low Estradiol Concentrations in Men With Subnormal Testosterone Concentrations and Type 2 Diabetes
por: Dhindsa, Sandeep, et al.
Publicado: (2011)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
por: Ved, Paresh, et al.
Publicado: (2012)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
por: Ved, Paresh, et al.
Publicado: (2013)

Association Between Intestinal Prevotella copri Abundance and Glycemic Fluctuation in Patients with Brittle Diabetes
por: Liu, Juan, et al.
Publicado: (2023)

Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study
por: Haider, Karim Sultan, et al.
Publicado: (2020)

Testosterone Concentration in Young Patients With Diabetes
por: Chandel, Anil, et al.
Publicado: (2008)

Importance of Glycemic Control in Cancer Patients with Diabetes: Treatment through End of Life
por: Hershey, Denise Soltow
Publicado: (2017)

Tight Glycemic Control and Cardiovascular Effects in Type 2 Diabetic Patients
por: Moodahadu, Latha Subramanya, et al.
Publicado: (2014)

Intraocular Pressure Fluctuation: Is It Important?
por: Kim, Ji Hyun, et al.
Publicado: (2018)

Polyunsaturated Fatty Acids and Glycemic Control in Type 2 Diabetes
por: Telle-Hansen, Vibeke H., et al.
Publicado: (2019)

Minimizing Hypoglycemia While Maintaining Glycemic Control in Diabetes
por: Heller, Simon R.
Publicado: (2008)

Effects of saxagliptin add-on therapy to insulin on blood glycemic fluctuations in patients with type 2 diabetes: A randomized, control, open-labeled trial
por: Li, Feng-fei, et al.
Publicado: (2016)

SAT-LB025 Analysis of Benefit/Risk in the Subgroup of Patients with BMI of >=27 Kg/m(2) in the Dapagliflozin DEPICT-1 and -2 Trials in Type 1 Diabetes
por: Mathieu, Chantal, et al.
Publicado: (2019)

Minimizing the risk of hypoglycemia with vildagliptin: Clinical experience, mechanistic basis, and importance in type 2 diabetes management
por: Dejager, Sylvie, et al.
Publicado: (2011)

Increase in Osteocalcin Following Testosterone Therapy in Men With Type 2 Diabetes and Subnormal Free Testosterone
por: Ghanim, Husam, et al.
Publicado: (2019)

Comment on: Wehr et al. Low Free Testosterone Levels Are Associated With All-Cause and Cardiovascular Mortality in Postmenopausal Diabetic Women. Diabetes Care 2011;34:1771–1777
por: Kuhadiya, Nitesh D., et al.
Publicado: (2012)

Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice
por: Sakamoto, Masaya
Publicado: (2018)

OR14-2 Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial
por: Dandona, Paresh, et al.
Publicado: (2019)

Diet and Glycemic Index in Children with Type 1 Diabetes
por: Quarta, Alessia, et al.
Publicado: (2023)

Effect of Dietary Approaches on Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review with Network Meta-Analysis of Randomized Trials
por: Jing, Tiantian, et al.
Publicado: (2023)

Depression, glycemic control and type 2 diabetes
por: Papelbaum, Marcelo, et al.
Publicado: (2011)

Enhanced glycemic control with combination therapy for type 2 diabetes in primary care
por: Kuritzky, Louis, et al.
Publicado: (2011)

Patient Preference and Satisfaction with the Use of Telemedicine for Glycemic Control in Patients with Type 2 Diabetes: A Review
por: Sim, Ruth, et al.
Publicado: (2021)

Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient-level pooled analysis
por: Chaudhuri, Ajay, et al.
Publicado: (2012)

Glycemic excursion minimization in the management of type 2 diabetes: a novel intervention tested in a randomized clinical trial
por: Cox, Daniel J, et al.
Publicado: (2020)

Ethnic Differences in Glycemic Markers in Patients With Type 2 Diabetes
por: Wolffenbuttel, Bruce H.R., et al.
Publicado: (2013)

Glycemic variability and cardiovascular disease in patients with type 2 diabetes
por: Martinez, Marcela, et al.
Publicado: (2021)

THU105 PHH Parameters Are New Minimal-Invasive Markers Of Glycemic Homeostasis Of Type 1 Diabetes
por: Harvengt, Antoine
Publicado: (2023)

LBSUN213 An Investigation Into The Effects Of Dapagliflozin On Ketogenesis In Type 1 Diabetes
por: Ghanim, Husam, et al.
Publicado: (2022)

Updated Review: Improved Glycemic Control with Repaglinide-Metformin in Fixed Combination for Patients with Type 2 Diabetes
por: Richard, John W., et al.
Publicado: (2011)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
por: Moses, Robert G
Publicado: (2010)

Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options
por: Du, Ye-Fong, et al.
Publicado: (2014)

Effect of glycemic control on markers of subclinical atherosclerosis in patients with type 2 diabetes mellitus: A review
por: Antoniou, Sofia, et al.
Publicado: (2021)

Diabetes knowledge and glycemic control among patients with type 2 diabetes in Bangladesh
por: Islam, Sheikh Mohammed Shariful, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ahhbpige5sod4kqsvt6pbkre7j